Response of bone turnover markers to bisphosphonate treatment in Paget's disease.

被引：0
|
作者：
Gill, KA [1 ]
Naylor, KE [1 ]
Ellison, JV [1 ]
Bainbridge, PR [1 ]
Eastell, R [1 ]
机构：
[1] Univ Sheffield, Div Clin Sci, Bone Metab Grp, Sheffield S10 2TN, S Yorkshire, England
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 1999年 / 14卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P52
引用
收藏
页码：1050 / 1050
页数：1
相关论文
共 50 条
  • [31] A comparison of serum and urine bone resorption markers in patients with Paget's disease.
    Naylor, KE
    Bainbridge, P
    Eastell, R
    JOURNAL OF BONE AND MINERAL RESEARCH, 1999, 14 : S541 - S541
  • [32] Severe hypocalcemia following bisphosphonate treatment in a patient with Paget's disease of bone
    Whitson, Heather E.
    Lobaugh, Bruce
    Lyles, Kenneth W.
    BONE, 2006, 39 (04) : 954 - 958
  • [33] Bone turnover markers in Paget's disease of the bone: A Systematic review and meta-analysis
    Al Nofal, A. A.
    Altayar, O.
    BenKhadra, K.
    Agha, O. Q. Qasim
    Asi, N.
    Nabhan, M.
    Prokop, L. J.
    Tebben, P.
    Murad, M. H.
    OSTEOPOROSIS INTERNATIONAL, 2015, 26 (07) : 1875 - 1891
  • [34] Bone turnover markers in Paget’s disease of the bone: A Systematic review and meta-analysis
    A. A. Al Nofal
    O. Altayar
    K. BenKhadra
    O. Q. Qasim Agha
    N. Asi
    M. Nabhan
    L. J. Prokop
    P. Tebben
    M. H. Murad
    Osteoporosis International, 2015, 26 : 1875 - 1891
  • [35] Zoledronate in the treatment of Paget's disease.
    Bhatia, A
    Chung, G
    Allsworth, A
    Keen, KW
    JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 : S389 - S389
  • [36] Long term response of biochemical markers of bone turnover and bone scintigraphic activity after 3 months of tiludronate treatment in Paget's disease:: Predictors of response to therapy
    Alvarez, L
    Guañabens, N
    Peris, P
    Vidal-Sicart, S
    Ros, I
    Monegal, A
    Bedini, JL
    Deulofeu, R
    Pons, F
    Ballesta, AM
    BONE, 2001, 28 (05) : S126 - S126
  • [37] Biochemical markers of bone turnover in the diagnosis of myeloma bone disease.
    Dizdar, O
    Barista, I
    Kalyoncu, U
    Karadag, O
    Celik, I
    Kars, A
    Tekuzman, G
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 585S - 585S
  • [38] Relationships between pharmacokinetics and rate of bone turnover after intravenous bisphosphonate (olpadronate) in patients with Paget's disease of bone
    Cremers, SCLM
    Eekhoff, MEMW
    Den Hartigh, J
    Hamdy, NAT
    Vermeij, P
    Papapoulos, SE
    JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 (05) : 868 - 875
  • [39] Early assessment of response to bisphosphonate therapy with biochemical markers of bone turnover
    Kagan, R
    Sebba, A
    Bonnick, S
    Chen, E
    Petruschke, R
    de Papp, A
    OBSTETRICS AND GYNECOLOGY, 2005, 105 (04): : 108S - 109S
  • [40] Mechanisms of abnormal bone turnover in Paget's disease
    Roodman, GD
    BONE, 1999, 24 (05) : 39S - 40S
12345